Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mera Pharmaceuticals is a marine biotechnology company specializing in the cultivation of microalgae for the production of high-value natural compounds. The company is best known for its proprietary photobioreactor technology, the Mera Growth System (MGS), which allows for the large-scale, controlled cultivation of specific algae strains. Its primary commercial focus was the production of natural astaxanthin, a potent antioxidant derived from the microalgae Haematococcus pluvialis, marketed under the brand name AstaFactor. Originally founded as Aquasearch, the firm transitioned to Mera Pharmaceuticals to explore broader pharmaceutical and nutraceutical applications of its algae-derived products. Despite its innovative technology, the company faced significant financial challenges and is currently considered inactive in the public markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mera Pharmaceuticals.